Showing results (601-610 of 2,462) with videos related to

Sort By:
Pageof 247
Therapie|May 21, 2016
[Vascular calcifications, the hidden side effects of vitamin K antagonists]Youssef Bennis, Subashini Vengadessane, Sandra Bodeau, et al.
Therapie|April 16, 2016
Clinical research and methodology: What usage and what hierarchical order for secondary endpoints?Silvy Laporte, Marine Diviné, Danièle Girault, et al.
Therapie|April 16, 2016
Pharmacoepidemiology and its input to pharmacovigilanceJean-Luc Faillie, François Montastruc, Jean-Louis Montastruc, et al.
Therapie|January 14, 2025
Organoids, organs-on-chips, complex in vitro model: Definitions, applications, validation, ethicsGuillaume Mottet, Alexandre Grassart, Philippe Barthélemy, et al.
Therapie|January 22, 2025
COVID-19 infection and risk of adverse drug reactions: Cohort studyPaul-Benoît Fargier, Marlène Damin-Pernik, Manon Launay, et al.
Therapie|December 18, 2024
Methodological expectations for demonstration of health product effectiveness by observational studiesMichel Cucherat, Olivier Demarcq, Olivier Chassany, et al.
Therapie|February 26, 2025
[HOPIPRAC: Pharmacovigilance interface for detecting cases of adverse events in a hospital data warehouse]Layal El Aridi, Hélène Jantzem, André Happe, et al.
Therapie|October 11, 2025
Digital pharmacological twins: Bridging multi-scale modelling and artificial intelligence for precision medicine: The DIGPHAT consortiumJean-Baptiste Woillard, Sébastien Benzekry, Julie Josse, et al.
Therapie|September 23, 2025
[Risk of mucocutaneous ulcerations associated with nicorandil: Recent data of the French Pharmacovigilance DataBase and Toulouse Hospital Discharge DataBase (NICORUC)]Liliane Batty, Joanna Lapalus, Elsa Trime, et al.
Therapie|December 30, 2020
[Adverse drug reactions profiles for abiraterone and enzalutamide: A pharmacovigilance descriptive analysis]Lucie-Marie Scailteux, Clémence Lacroix, Sandrine Bergeron, et al.
Pageof 247